You are subscribed to the FormularyWatch.

Formulary

eNewsletter Subscribe

June 26, 2014

Web Version  | Share with a colleague

Facebook Like Twitter Tweet

Today's Headlines

Testosterone products: FDA requires labeling to include risk of VTE

FDA is requiring manufacturers of all approved testosterone products to include a warning in the drug labeling about the risk of blood clots in the veins, also known as venous thromboembolism, including deep vein thrombosis and pulmonary embolism.
» Full article

FDA antidepressant warnings may have led to more teen suicide attempts: Study

There is a need for greater coordination of federal drug risk communications by FDA with the media to avoid exaggerated messages to the public, according to a recent study. » Full article

Continuing Education

MTM essentials for heart failure management

This month's article is the fifth in a year-long CPE series, Medication Therapy Management Considerations for Adult Patients with Cardiovascular Disease. From February 2014 through January 2015, pharmacists can earn up to 24 hours of CPE credit with 12 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to review the stages and pharmacologic strategies relevant to medication therapy management of heart failure.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to log in.


Announcement: Welcome to the new user registration process. This new process requires all pharmacists and pharmacy technicians to provide or update their NABP e-Profile ID in order to electronically keep track of CPE credits from ACPE-accredited providers. If you have not done so, you can obtain your NABP e-Profile ID now at www.MyCPEmonitor.net. This profile will enable you to have one login for all the NABP programs and services you will need throughout your career.

 

Related Articles

FDA approves another testosterone replacement gel

[INFOGRAPHIC]: E-cigarette use tied to smoking in teens

RESOURCES

Latest Clinical News

EDITOR'S PICK

Get the latest clinical information from the ADA

Dulaglutide: Effective blood glucose control in diabetes

Safety, efficacy profile for new insulin glargine product

Empagliflozin controlled patients with type 2 diabetes on multiple daily insulin injections

Empagliflozin with metformin: Greater reductions in blood glucose, body weight vs glimepiride

Canola oil helps with blood glucose in type 2 diabetes

Powered by Modern Medicine Advanstar Medical Communications Group